XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.3
Note 6 - Goodwill and Intangible Assets, Net
6 Months Ended
Sep. 30, 2024
Notes to Financial Statements  
Goodwill and Intangible Assets Disclosure [Text Block]

Note 6. Goodwill and Intangible Assets, Net

 

Finite-lived intangible assets consisted of the following:

 

  

September 30, 2024

  

March 31, 2024

 
  

Gross Carrying Amount

  

Accumulated Amortization

  

Net Carrying Amount

  

Gross Carrying Amount

  

Accumulated Amortization

  

Net Carrying Amount

 

Customer relationships

 $194,931  $(113,003) $81,928  $189,911  $(104,528) $85,383 

Other intangibles

  62,320   (35,425)  26,895   61,161   (32,792)  28,369 

Total finite-lived intangible assets

 $257,251  $(148,428) $108,823  $251,072  $(137,320) $113,752 

 

Amortization expense for finite-lived intangible assets was as follows:

 

  

Three Months Ended September 30,

  

Six Months Ended September 30,

 
  

2024

  

2023

  

2024

  

2023

 

Amortization in cost of revenues

 $672  $1,756  $1,319  $3,484 

Amortization in general and administrative

  3,878   5,429   7,292   10,921 

Total amortization expense

 $4,550  $7,185  $8,611  $14,405 

 

For the following fiscal years ending March 31, amortization expense is estimated as follows, based on foreign currency exchange rates as of September 30, 2024:

 

Fiscal Year

 Amortization Expense 
  

Remainder of 2025

 $9,118 

2026

  17,586 

2027

  16,915 

2028

  16,301 

2029

  15,729 

  

The change in the carrying amount of goodwill was as follows:

 

  

Sterilization and Disinfection Control

  

Clinical Genomics

  

Biopharmaceutical Development

  

Calibration Solutions

  

Total

 

March 31, 2024

 $79,430  $16,940  $46,515  $37,211   180,096 

Effect of foreign currency translation

  1,979   116   1,530   32   3,657 

September 30, 2024

 $81,409  $17,056  $48,045  $37,243  $183,753